文献
J-GLOBAL ID:201802218546956568
整理番号:18A0236745
急性骨髄性白血病患者の再誘導のためのミトキサントロン,エトポシド,およびシタラビンと併用したレナリドマイド+化学療法の第I相試験【Powered by NICT】
A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia
著者 (19件):
DeAngelo Daniel J.
(Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Brunner Andrew M.
(Massachusetts General Hospital, Boston, Massachusetts)
,
Werner Lillian
(Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Avigan David
(Beth-Israel Deaconess Medical Center, Boston, Massachusetts)
,
Fathi Amir T.
(Massachusetts General Hospital, Boston, Massachusetts)
,
Sperling Adam S.
(Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Washington Abigail
(Beth-Israel Deaconess Medical Center, Boston, Massachusetts)
,
Stroopinsky Dina
(Beth-Israel Deaconess Medical Center, Boston, Massachusetts)
,
Rosenblatt Jacalyn
(Beth-Israel Deaconess Medical Center, Boston, Massachusetts)
,
McMasters Malgorzata
(Beth-Israel Deaconess Medical Center, Boston, Massachusetts)
,
Luptakova Katarina
(Takeda Oncology, Cambridge, Cambridge, MA)
,
Wadleigh Martha
(Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Steensma David P.
(Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Hobbs Gabriela S.
(Massachusetts General Hospital, Boston, Massachusetts)
,
Attar Eyal C.
(Agios Pharmaceuticals, Cambridge, Cambridge, MA)
,
Amrein Philip C.
(Massachusetts General Hospital, Boston, Massachusetts)
,
Ebert Benjamin L.
(Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Stone Richard M.
(Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Ballen Karen K.
(University of Virginia, Charlottesville, Virginia)
資料名:
American Journal of Hematology
(American Journal of Hematology)
巻:
93
号:
2
ページ:
254-261
発行年:
2018年
JST資料番号:
E0721B
ISSN:
0361-8609
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)